Abstract
A case is presented of a severe bleeding diathesis associated with moxalactam administration that was confirmed on rechallenge. Potential mechanisms of action and recommendations for patient monitoring are discussed.
Get full access to this article
View all access options for this article.
References
1.
Ham
JM
. Hypoprothrombinemia in patients undergoing prolonged intensive care . Med J Aust
1971 ; 2 : 716 –8 .
2.
Pakter
RL
Russell
TR
Mielke
H
West
D
. Coagulopathy associated with the use of moxalactam . JAMA
1982 ; 248 : 1100 .
3.
Holt
RJ
Gorrochategui
M
Perez
C
. Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to
Citrobacter diversus. Drug Intell Clin Pharm
1981 ; 15 : 288 –9 .
4.
Panwalker
AP
Rosenfeld
J
. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam (letter) . J Infect Dis
1983 ; 147 : 171 –2 .
5.
Andrassy
K
Koderisch
J
Ritz
E
. Influence of cefotaxime, cefoperazone, and moxalactam on hemostasis . 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Oct., 1982 , Miami Beach, FL (Abstract 523).
6.Prescribing Information. Moxam. Eli Lilly and Co., Indianapolis, IN, June, 1983 .
7.
Jensen
BC
. Moxalactam-induced coagulopathy (letter) . Clin Pharm
1983 ; 2 : 301 –2 .
8.
Meisel
S
. Hypoprothrombinemia due to cefoperazone . Drug Intell Clin Pharm
1984 ; 18 : 316 .
9.
Hooper
CA
Haney
BB
Stone
HH
. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole . Lancet
1980 ; 1 : 39 –40 .
10.
Rymer
W
Greenlaw
CW
. Hypoprothrombinemia associated with cefamandole . Drug Intell Clin Pharm
1980 ; 14 : 780 –3 .
11.
Lee
S
Spira
S
Gabor
EP
. Coagulopathy associated with moxalactam (letter) . JAMA
1983 ; 249 : 2019 –20 .
12.
Jones
SR
Kimbrough
RC
. Moxalactam and hemorrhage (letter) . Ann Intern Med
1983 ; 99 : 126 .
13.
Weitekamp
MR
Aber
RC
. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration . JAMA
1983 ; 249 : 69 –71 .
14.
Gynn
TN
Messmore
HL
Friedman
IA
. Drug induced thrombocytopenia . Med Clin North Am
1972 ; 56 : 65 –79 .
15.
Neu
HC
. Adverse effects of new cephalosporins (letter) . Ann Intern Med
1983 ; 98 : 415 .
16.
Quintiliani
R
. Bleeding disorders associated with newer cephalosporins (editorial) . Clin Pharm
1983 ; 2 : 360 –1 .
17.
Bang
NU
Kammer
RB
. Hematologic complications associated with β-lactam antibiotics . Rev Infect Dis
1983 ; 5 : S380 –93 .